Is this you? Create Your Porfile
Avatar

Schadt Oliver

Merck & Co.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Schadt Oliver is active.

Explore More

Publication

Featured researches published by Schadt Oliver.

Archive | 2002

Harnstoff- und Urethanderivate

Staehle Wolfgang; Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2003

BIPHENYL THIOAMIDES SERVING AS INTEGRIN RECEPTOR ANTAGONISTS

Staehle Wolfgang; Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2002

alphavbeta3 integrin inhibitors

Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2001

Novel integrin alpha v beta 3 inhibitors

Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2002

New glycine N-(1-biphenyl-4-yl-2-substituted-ethyl)-amides, are integrin receptor inhibitors useful for treating e.g. angiogenic, cardiovascular, inflammatory and osteolytic or tumor diseases

Staehle Wolfgang; Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2001

Inhibitoren des Integrins alphavbeta¶3¶

Jonczyk Alfred; Schadt Oliver; Goodman Simon

Archive | 2012

Derivados de ácido 3-alcanoilamino-propiónico como inhibidores de la integrina AVSS6

Staehle Wolfgang; Schadt Oliver; Jonczyk Alfred; Goodman Simon

Archive | 2009

INHIBIDORES DE LA INTEGRINA ALFA-V-BETA-6.

Schadt Oliver; Jonczyk Alfred; Stahle Wolfgang; Goodman Simon

Archive | 2009

Inhibitors of integrin alphanubeta6

Schadt Oliver; Jonczyk Alfred; Staehle Wolfgang; Goodman Simon

Archive | 2008

INHIBITOREN VON INTEGRIN ALPHA-V-BETA-6

Schadt Oliver; Jonczyk Alfred; Staehle Wolfgang; Goodman Simon

Explore More

Collaboration

Dive into the Schadt Oliver's collaboration.

Top Co-Authors
Avatar

Goodman Simon

Merck

View shared research outputs
Top Co-Authors
Avatar

Jonczyk Alfred

Merck

View shared research outputs
Top Co-Authors
Avatar

Staehle Wolfgang

Merck

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge